Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.400
+0.070 (3.00%)
At close: Mar 18, 2026
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 867.57 million as of March 18, 2026. Its market cap has increased by 8.59% in one year.
Market Cap
867.57M
Enterprise Value
1.44B
Revenue
767.82M
Ranking
n/a
PE Ratio
62.11
Stock Price
2.40
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 867.57M, an increase of 228.91%. That is a compound annual growth rate of 12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 867.57M | -8.36% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.35B |
| Healius | 417.53M |
| Australian Clinical Labs | 381.75M |
| Monash IVF Group | 245.47M |
| Rhythm Biosciences | 68.92M |
| Cryosite | 58.33M |
| Microba Life Sciences | 48.72M |
| INOVIQ | 47.16M |